Frontier Biotechnologies Inc. (SHA:688221)

Frontier Biotechnologies Revenue

Frontier Biotechnologies had revenue of 297.13M CNY in the quarter ending March 31, 2026, with 948.89% growth. This brings the company's revenue in the last twelve months to 392.19M, up 194.54% year-over-year. In the year 2025, Frontier Biotechnologies had annual revenue of 123.39M, down -4.70%.

• Revenue (ttm): 392.19M
• Revenue Growth: +194.54%
• P/S Ratio: 17.54
• Revenue / Employee: 1.25M
• Employees: 314
• Market Cap: 6.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	123.39M	-6.09M	-4.70%
Dec 31, 2024	129.47M	15.22M	13.32%
Dec 31, 2023	114.25M	29.51M	34.82%
Dec 31, 2022	84.74M	44.24M	109.22%
Dec 31, 2021	40.50M	-6.12M	-13.13%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error